Sunday, 14 July 2024

Korean startup Lunit delivers AI-powered cancer screening solution to France and Portugal

18 March 2024 | News

To bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to the Central region branch of the Portuguese League against cancer

Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has announced two commercial deals that signal its expansion in Europe.

The Korean startup has secured a supply contract with TeleDiag in France and the Portuguese League Against Cancer (Liga Portuguesa Contra o Cancro; LPCC), providing AI-powered radiology solutions for chest X-ray and breast cancer detection, respectively.

By delivering Lunit INSIGHT CXR, a CE-marked AI-powered solution to detect 10 of the most common lung abnormalities, including lung cancer, Lunit and TeleDiag aim to enhance the accuracy and effectiveness of lung disease detection. As TeleDiag regroups a vast network of over 600 radiologists serving more than 300 medical practices and screening over 600,000 patients annually, the collaboration represents a significant leap forward in the integration of AI technology into the French healthcare system.

In parallel, Lunit has inked a supply agreement with the central region branch of the Portuguese League Against Cancer (LPCC), to deliver its FDA-cleared and CE-marked AI-powered solution for mammography analysis, Lunit INSIGHT MMG. The central region branch of LPCC plans to analyse about 100,000 mammograms annually for the next three years using Lunit INSIGHT MMG.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account